Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;28(2):145-6.
doi: 10.1007/BF00689706.

Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872

A S Planting  1 , A Ardizzoni, J Estapé, G Giaccone, G Scagliotti, T A Splinter, A Kirkpatrick, O Dalesio, J G McVie
Affiliations
Free article

Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872

A S Planting et al. Cancer Chemother Pharmacol. 1991.
Free article

Abstract

A total of 62 patients with metastatic or locally advanced non-small-cell lung cancer were entered in a phase II study of ACNU. Initially, the drug was given i.v. at a dose of 100 mg/m2 every 6 weeks, but due to observed haematological side effects in chemotherapy-pretreated patients, the dose was lowered in this group to 75 mg/m2. We observed one complete response in a subject exhibiting multiple lung metastases and a partial response in two patients, one showing brain metastases and one who experienced local disease recurrence. The toxicity of ACNU mainly consisted of bone marrow suppression especially thrombocytopenia, with one toxic death occurring due to intracerebral haemorrhage. We concluded that at this dose and on this schedule, ACNU has limited activity in non-small-cell lung cancer.

PubMed Disclaimer

References

    1. Cancer Chemother Pharmacol. 1988;21(2):89-102 - PubMed
    1. Eur J Cancer Clin Oncol. 1985 Dec;21(12):1557-9 - PubMed
    1. Cancer Chemother Pharmacol. 1980;4(3):165-71 - PubMed
    1. Gan. 1978 Aug;69(4):545-8 - PubMed

LinkOut - more resources